Dr. Jiangyan Yu is a bioinformatician whose research integrates computational method development, long-read sequencing technologies, and artificial intelligence to advance cancer research and translational medicine. She focuses on developing advanced computational programs for the analysis of long-read sequencing data and applying these technologies to elucidate complex molecular mechanisms in cancer. In addition, Dr. Yu develops AI-driven tools for translational medicine, with particular interests in multimodal-based cancer subtype classification and treatment outcome prediction.